Cure My Disease

Don't miss your cure!

 Log in / Sign up

Drug safety under scrutiny for emergency bleeding treatment

NCT ID NCT05454787

Recruiting now Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This study aims to monitor the safety of a drug called Ondexxya, which is used in emergencies to reverse the effects of certain blood thinners in patients with life-threatening bleeding. It will enroll 300 patients who received the drug in real-world hospital settings. The main goal is to track side effects, especially blood clots and reactions to the infusion, to better understand the drug's safety profile.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FACTOR XA INHIBITOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Research Site

    WITHDRAWN

    Aichi, Japan

  • Research Site

    ACTIVE_NOT_RECRUITING

    Aichi, Japan

  • Research Site

    RECRUITING

    Aichi, Japan

  • Research Site

    WITHDRAWN

    Akita, Japan

  • Research Site

    WITHDRAWN

    Aomori, Japan

  • Research Site

    WITHDRAWN

    Chiba, Japan

  • Research Site

    ACTIVE_NOT_RECRUITING

    Chiba, Japan

  • Research Site

    NOT_YET_RECRUITING

    Chiba, Japan

  • Research Site

    ACTIVE_NOT_RECRUITING

    Ehime, Japan

  • Research Site

    WITHDRAWN

    Ehime, Japan

  • Research Site

    WITHDRAWN

    Fukui, Japan

  • Research Site

    ACTIVE_NOT_RECRUITING

    Fukui, Japan

  • Research Site

    WITHDRAWN

    Fukuoka, Japan

  • Research Site

    ACTIVE_NOT_RECRUITING

    Fukuoka, Japan

  • Research Site

    WITHDRAWN

    Fukushima, Japan

  • Research Site

    WITHDRAWN

    Gifu, Japan

  • Research Site

    ACTIVE_NOT_RECRUITING

    Gifu, Japan

  • Research Site

    WITHDRAWN

    Gunma, Japan

  • Research Site

    ACTIVE_NOT_RECRUITING

    Gunma, Japan

  • Research Site

    RECRUITING

    Gunma, Japan

  • Research Site

    WITHDRAWN

    Hiroshima, Japan

  • Research Site

    WITHDRAWN

    Hokkaido, Japan

  • Research Site

    ACTIVE_NOT_RECRUITING

    Hokkaido, Japan

  • Research Site

    WITHDRAWN

    Hyōgo, Japan

  • Research Site

    ACTIVE_NOT_RECRUITING

    Hyōgo, Japan

  • Research Site

    WITHDRAWN

    Ibaraki, Japan

  • Research Site

    WITHDRAWN

    Ishikawa, Japan

  • Research Site

    WITHDRAWN

    Kagawa, Japan

  • Research Site

    WITHDRAWN

    Kagoshima, Japan

  • Research Site

    WITHDRAWN

    Kanagawa, Japan

  • Research Site

    ACTIVE_NOT_RECRUITING

    Kanagawa, Japan

  • Research Site

    WITHDRAWN

    Kochi, Japan

  • Research Site

    WITHDRAWN

    Kumamoto, Japan

  • Research Site

    ACTIVE_NOT_RECRUITING

    Kumamoto, Japan

  • Research Site

    ACTIVE_NOT_RECRUITING

    Kyoto, Japan

  • Research Site

    WITHDRAWN

    Kyoto, Japan

  • Research Site

    WITHDRAWN

    Mie, Japan

  • Research Site

    ACTIVE_NOT_RECRUITING

    Mie, Japan

  • Research Site

    WITHDRAWN

    Miyagi, Japan

  • Research Site

    WITHDRAWN

    Miyazaki, Japan

  • Research Site

    WITHDRAWN

    Nagano, Japan

  • Research Site

    ACTIVE_NOT_RECRUITING

    Nagano, Japan

  • Research Site

    WITHDRAWN

    Nagasaki, Japan

  • Research Site

    RECRUITING

    Nagasaki, Japan

  • Research Site

    WITHDRAWN

    Nara, Japan

  • Research Site

    WITHDRAWN

    Niigata, Japan

  • Research Site

    ACTIVE_NOT_RECRUITING

    Niigata, Japan

  • Research Site

    WITHDRAWN

    Numakunai, Japan

  • Research Site

    WITHDRAWN

    Okayama, Japan

  • Research Site

    WITHDRAWN

    Okinawa, Japan

  • Research Site

    WITHDRAWN

    Osaka, Japan

  • Research Site

    ACTIVE_NOT_RECRUITING

    Osaka, Japan

  • Research Site

    WITHDRAWN

    Saga, Japan

  • Research Site

    WITHDRAWN

    Saitama, Japan

  • Research Site

    WITHDRAWN

    Shiga, Japan

  • Research Site

    ACTIVE_NOT_RECRUITING

    Shiga, Japan

  • Research Site

    WITHDRAWN

    Shimane, Japan

  • Research Site

    WITHDRAWN

    Shizuoka, Japan

  • Research Site

    WITHDRAWN

    Tochigi, Japan

  • Research Site

    ACTIVE_NOT_RECRUITING

    Tochigi, Japan

  • Research Site

    WITHDRAWN

    Tokushima, Japan

  • Research Site

    WITHDRAWN

    Tokyo, Japan

  • Research Site

    ACTIVE_NOT_RECRUITING

    Tokyo, Japan

  • Research Site

    ACTIVE_NOT_RECRUITING

    Tottori, Japan

  • Research Site

    WITHDRAWN

    Toyama, Japan

  • Research Site

    WITHDRAWN

    Wakayama, Japan

  • Research Site

    ACTIVE_NOT_RECRUITING

    Wakayama, Japan

  • Research Site

    WITHDRAWN

    Yamagata, Japan

  • Research Site

    ACTIVE_NOT_RECRUITING

    Yamagata, Japan

  • Research Site

    WITHDRAWN

    Yamaguchi, Japan

  • Research Site

    ACTIVE_NOT_RECRUITING

    Yamaguchi, Japan

  • Research Site

    WITHDRAWN

    Yamanashi, Japan

Conditions

Explore the condition pages connected to this study.

FACTOR XA INHIBITOR LIFE THREATENING BLEEDING